Uses advanced algorithms to assess symptoms through conversational questioning and provide evidence-based recommendations.
Enables patients to input health data for continuous tracking, with alerts sent to healthcare providers for timely interventions.
Seamlessly connects with electronic health records to synchronize patient data and enhance care coordination.
Natural language processing allows for intuitive, context-aware interactions with users in a chat-based format.
Provides detailed insights into user engagement, health outcomes, and platform performance through customizable dashboards.
Available in multiple languages to serve diverse populations, with automatic detection and translation capabilities.
Allows organizations to white-label the platform with their own branding, logos, and user interface elements.
Helps patients with conditions like diabetes or hypertension track symptoms, adhere to treatment plans, and receive personalized reminders.
Screens patients before virtual consultations to prioritize cases and direct them to appropriate care levels.
Provides initial assessments, resources, and guidance for mental health concerns, reducing stigma and improving access.
Offers health tips, vaccination reminders, and screening recommendations to promote wellness and early detection.
Monitors patients after hospital discharge to prevent readmissions and ensure recovery through regular check-ins.
Used by employers to engage employees with health challenges, reduce absenteeism, and promote a healthy workplace.
Helps insurers educate members on benefits, manage claims, and provide proactive health support.
Extends healthcare services to underserved areas with limited providers through virtual assistance and remote monitoring.
Assists parents in managing children's health issues with age-appropriate guidance and symptom assessment.
Provides initial assessment during emergencies to guide users to appropriate care settings and reduce emergency room overload.
Sign in to leave a review
Activ Surgical is an innovative medical technology company that develops intelligent surgical systems designed to enhance precision and outcomes in various surgical procedures. Their platform leverages artificial intelligence (AI), augmented reality (AR), and computer vision to provide real-time visualization and data-driven guidance during surgeries. Aimed at improving patient safety and reducing complications, the technology integrates seamlessly with existing surgical equipment, such as endoscopes and imaging systems, to overlay critical anatomical information and optimize surgical paths. This assists surgeons in making informed decisions, particularly in minimally invasive and complex open surgeries. By digitizing surgical processes, Activ Surgical contributes to the advancement of surgical care through enhanced efficiency, accuracy, and training capabilities. The system is adaptable across multiple surgical specialties, supporting a future where AI-driven tools become standard in operating rooms for better healthcare delivery.
BenevolentAI is a technology company that leverages artificial intelligence to accelerate and enhance drug discovery and development processes. By integrating vast biomedical datasets with advanced machine learning algorithms, the platform enables researchers to identify novel drug targets, predict drug efficacy and safety, optimize clinical trial designs, and repurpose existing drugs for new indications. Focused on addressing diseases with high unmet medical needs, such as cancer and neurological disorders, BenevolentAI aims to transform the pharmaceutical industry by reducing the time, cost, and failure rates associated with bringing new therapies to market. The platform combines AI-driven insights with domain expertise, providing a collaborative environment for scientists to generate hypotheses, validate candidates, and streamline decision-making in research pipelines. Its comprehensive approach includes data analysis, predictive modeling, and integration with existing laboratory systems, making it a powerful tool for biotech and pharma companies seeking innovation in drug development.
Biofourmis is a pioneering digital health company that specializes in AI-driven remote patient monitoring and personalized care solutions. Their flagship platform, Biovitals, leverages advanced machine learning algorithms to analyze continuous physiological data collected from wearable sensors. This enables healthcare providers to monitor patients in real-time, detect early signs of health deteriorations, and intervene proactively. The platform is designed to manage a wide range of clinical conditions, including chronic heart failure, diabetes, hypertension, and post-operative recovery. By integrating seamlessly with electronic medical record systems, Biofourmis facilitates efficient data flow and enhances clinical decision-making. The company serves various stakeholders, from large hospital systems to pharmaceutical companies conducting decentralized clinical trials. Biofourmis aims to improve patient outcomes, reduce hospital readmissions, and lower healthcare costs through data-driven insights. Their technology is scalable, secure, and compliant with global healthcare regulations, making it a trusted partner in transforming care delivery. With a focus on innovation, Biofourmis continues to expand its capabilities, offering tools for predictive analytics, personalized treatment plans, and population health management.
